Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMX4 antisense RNA 1 (TMX4-AS1) is a long non-coding RNA (lncRNA) gene, transcribed from the opposite strand of the TMX4 locus[5]. It does not encode a protein but may regulate gene expression through antisense mechanisms. There is currently no evidence that TMX4-AS1 is a validated therapeutic target, receptor, enzyme, transporter, or similar entity. Its biological functions and roles in disease are not well described in the scientific literature. Care should be taken to distinguish TMX4-AS1 from the protein-coding TMX4 gene (Thioredoxin-related transmembrane protein 4), which is an endoplasmic reticulum reductase involved in protein folding[1][3]. Available public gene databases list basic annotation for TMX4-AS1, but no well-characterized molecular function, disease link, or drug interaction is established[5]. If you are seeking information on the protein-coding TMX4 gene or circular/linear non-coding transcripts of TMX4, consult relevant entries for those terms, as TMX4-AS1 is a separate antisense RNA species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMX4 antisense RNA 1 (TMX4-AS1).